2.3. Eligible Patients
malignancy, ascites
ASCITES, PANCREATIC CANCER
The main inclusion criteria are as follows: patients aged ≥ 18years who meet the diagnostic criteria and expressed written willingness to participate in the study by signing the informed consent, life expectancy equal to or greater than 3 months, clinical status according to ECOG criteria ≤ 2, and patients fit for chemotherapy and with normal renal and hepatic function according to laboratory parameters.The main exclusion criteria are as follows: prior anticancer chemotherapy including adjuvant gemcitabine for pancreatic cancer, any investigational agent received concurrently or within the last 30 days, major surgery within the previous 3 weeks, previous or concurrent malignancy other than pancreatic cancer, uncontrolled ascites, or other clinically significant comorbidities.